Mar. 29 at 1:47 AM
$PXMD PAX-101 looking promising for ASD and HAT. FDA meetings seem positive. Potential game-changer in neurological treatments. Watching closely for NDA submissions. Could be big if approvals come through. a closer look at current performance: https://beyondspx.com/article/paxmedica-inc-otc-pxmd-pioneering-treatments-for-neurological-disorders